Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04655183
Title Study of M4344 in Combination With Niraparib
Recruitment Withdrawn
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors EMD Serono Research & Development Institute, Inc.
Indications

Advanced Solid Tumor

Her2-receptor negative breast cancer

Therapies

Niraparib + VX-803

Niraparib

Age Groups: senior | adult
Covered Countries

Facility Status City State Zip Country Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field